This new Summit, organised by The Lancet Respiratory Medicine and The Lancet Oncology, will cover all of the main areas of debate for patients with COPD and lung cancer from prevention, diagnosis, treatment through to palliative care.

 

 

The Lancet Summit: COPD and Lung Cancer takes place in Perth, Australia 28-29 July 2017.

 

If you have not already booked please remember special rates apply for members of MOGA: just select the Supporting Partner rate during registration.

 

Organised by The Lancet Respiratory Medicine and The Lancet Oncology and with participation from around the Asia Pacific region, the meeting promises to encourage networking and collaboration between respiratory and lung cancer specialists.

 

In a unique two-day programme, more than 20 expert international speakers who will give invited talks and share insight on all aspects of COPD and lung cancer from prevention, diagnosis, treatment through to palliative care. This is supplemented by a poster session and clinical trials reports.

 

Full programme and registration information is detailed at: http://www.thelancetsummit.com

 

Members of ETOP are entitled to a discount on the registration fee. Please select the relevant Supporting Society Member rate during online registration.